Aug. 27 at 7:37 PM
$FDXTF I am initiating coverage on this today. They have crossed some milestones that will grow into massive sales volumes I believe with the approval of their 510k coming. A Cather device that unlike any other. I will explain more over several days. Target is
$5-
$8 with major collaborations expected. Only 2 million in float and that is all tightly held. CEO is former major pharmaceutical management.